Latest financial market updates and expert analysis
Analysis The arithmetic at Curis has become brutally simple. The clinical-stage biotech burned through $8.58 million in the second quarter, ended June with just $5.1 million in the bank, and then...
The memory-chip giant has plenty on its plate this week. A tentative wage agreement with its South Korean union, a...
The numbers coming out of Rocket Lab’s operations read like a growth investor’s wish list. Second-quarter revenue hit $234 million,...
The arithmetic coming out of Micron Technology these days is almost impossible to ignore. The memory-chip maker has locked in...
The Danish pharmaceutical giant is navigating one of its most consequential stretches in years, juggling a clinical setback, a courtroom...
Silver’s latest advance has carried the metal to the doorstep of a level that chartists have been watching for weeks....
The arithmetic is stark: thirty shares become one. That is the proposal NurExone Biologic will put before shareholders at its...
The market’s verdict on Lenzing is split down the middle. The Austrian fibre producer’s stock has clawed back roughly 21...
The cannabis giant’s Wall Street honeymoon is getting a second act. Trulieve rang the NYSE closing bell on Tuesday to...
The humanoid robotics sector has a new darling, and it is not Ubtech Robotics. When rival Unitree Robotics stormed onto...
There are days on Wall Street when a single headline rewrites the calculus for an entire industry. Friday was one...
